Pfizer Inc. Reports Completion of $6 Billion Public Debt Offering
Summary
On November 21, 2025, Pfizer Inc. completed a public offering of notes totaling $6,000,000,000 aggregate principal amount (via Ex. 5.1). The offering included seven tranches of notes with various rates and maturities, ranging from Floating Rate Notes due 2027 to 5.700% Notes due 2065. These notes were issued pursuant to a Sixth Supplemental Indenture, dated November 21, 2025, which supplements the Base Indenture from September 7, 2018 (via Ex. 4.2).
Why It Matters
This significant public debt offering of $6 billion provides Pfizer Inc. with substantial capital, materially impacting its financial structure and future liquidity.
These filing summaries are free and always will be. If this helped you spot material events, consider supporting us.
Want to see how PFE traded around this filing?
Check real-time charts and technical analysis on TradingView to see market reaction to this event.
View PFE Charts on TradingViewAffiliate link
Key Quote
“On November 21, 2025, Pfizer Inc. (the "Company") completed a public offering of $500,000,000 aggregate principal amount of Floating Rate Notes due 2027 (the "Floating Rate Notes"), $1,000,000,000 aggregate principal amount of 3.”
— From Item 8.01
Filing Details
Reported Items
Additional Information
- CIK Number
- 0000078003
- Filing Date
- Friday, November 21, 2025
- Filing Time
- 12:00 AM UTC
- Form Type
- 8-K
- Materiality Level
- high
- Sentiment
- neutral